BOSTON OMAHA CORP-CL A (BOC) Stock Fundamental Analysis

NYSE:BOC • US1010441053

12.5 USD
+0.19 (+1.54%)
At close: Feb 13, 2026
12.5 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, BOC scores 3 out of 10 in our fundamental rating. BOC was compared to 93 industry peers in the Media industry. BOC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BOC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year BOC has reported negative net income.
  • BOC had a positive operating cash flow in the past year.
  • In multiple years BOC reported negative net income over the last 5 years.
  • BOC had a positive operating cash flow in 4 of the past 5 years.
BOC Yearly Net Income VS EBIT VS OCF VS FCFBOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.03%, BOC is in the better half of the industry, outperforming 65.59% of the companies in the same industry.
  • BOC has a Return On Equity of -0.04%. This is in the better half of the industry: BOC outperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -0.03%
ROE -0.04%
ROIC N/A
ROA(3y)-0.02%
ROA(5y)1.3%
ROE(3y)-0.04%
ROE(5y)2.1%
ROIC(3y)N/A
ROIC(5y)N/A
BOC Yearly ROA, ROE, ROICBOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • The Gross Margin of BOC (67.24%) is better than 84.95% of its industry peers.
  • BOC's Gross Margin has declined in the last couple of years.
  • BOC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y-1.7%
BOC Yearly Profit, Operating, Gross MarginsBOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • BOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BOC has about the same amount of shares outstanding.
  • Compared to 5 years ago, BOC has more shares outstanding
  • BOC has a worse debt/assets ratio than last year.
BOC Yearly Shares OutstandingBOC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BOC Yearly Total Debt VS Total AssetsBOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.45, we must say that BOC is in the distress zone and has some risk of bankruptcy.
  • BOC has a better Altman-Z score (1.45) than 65.59% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that BOC is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.08, BOC is doing good in the industry, outperforming 74.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.45
ROIC/WACCN/A
WACC8.28%
BOC Yearly LT Debt VS Equity VS FCFBOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • BOC has a Current Ratio of 2.07. This indicates that BOC is financially healthy and has no problem in meeting its short term obligations.
  • BOC has a Current ratio of 2.07. This is in the better half of the industry: BOC outperforms 76.34% of its industry peers.
  • BOC has a Quick Ratio of 2.07. This indicates that BOC is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of BOC (2.07) is better than 78.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07
BOC Yearly Current Assets VS Current LiabilitesBOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 100.00% over the past year.
  • The Revenue has been growing slightly by 6.92% in the past year.
  • BOC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.21% yearly.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)6.92%
Revenue growth 3Y23.87%
Revenue growth 5Y21.21%
Sales Q2Q%3.73%

3.2 Future

  • The Earnings Per Share is expected to decrease by -42.13% on average over the next years. This is quite bad
  • Based on estimates for the next years, BOC will show a small growth in Revenue. The Revenue will grow by 4.54% on average per year.
EPS Next Y-430.25%
EPS Next 2Y-42.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BOC Yearly Revenue VS EstimatesBOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BOC Yearly EPS VS EstimatesBOC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Forward Price/Earnings Ratio is negative for BOC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BOC Price Earnings VS Forward Price EarningsBOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BOC.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.29
BOC Per share dataBOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A cheap valuation may be justified as BOC's earnings are expected to decrease with -42.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.13%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BOC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BOSTON OMAHA CORP-CL A

NYSE:BOC (2/13/2026, 8:04:00 PM)

After market: 12.5 0 (0%)

12.5

+0.19 (+1.54%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13
Earnings (Next)03-26
Inst Owners69.48%
Inst Owner ChangeN/A
Ins Owners3.94%
Ins Owner Change0.78%
Market Cap393.13M
Revenue(TTM)112.60M
Net Income(TTM)-231.30K
Analysts45
Price Target14.28 (14.24%)
Short Float %4.99%
Short Ratio8.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-273.93%
Min EPS beat(2)-331.02%
Max EPS beat(2)-216.83%
EPS beat(4)1
Avg EPS beat(4)23.93%
Min EPS beat(4)-331.02%
Max EPS beat(4)941.58%
EPS beat(8)1
Avg EPS beat(8)-103.94%
EPS beat(12)3
Avg EPS beat(12)320.2%
EPS beat(16)3
Avg EPS beat(16)-316.28%
Revenue beat(2)0
Avg Revenue beat(2)-3.2%
Min Revenue beat(2)-5.02%
Max Revenue beat(2)-1.39%
Revenue beat(4)2
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)1.31%
Revenue beat(8)4
Avg Revenue beat(8)-0.6%
Revenue beat(12)7
Avg Revenue beat(12)0.23%
Revenue beat(16)9
Avg Revenue beat(16)0.79%
PT rev (1m)0%
PT rev (3m)-22.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.49
P/FCF N/A
P/OCF 18.46
P/B 0.74
P/tB 1.34
EV/EBITDA 13.29
EPS(TTM)0
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)0.68
OCFY5.42%
SpS3.58
BVpS16.8
TBVpS9.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.03%
ROE -0.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.24%
FCFM N/A
ROA(3y)-0.02%
ROA(5y)1.3%
ROE(3y)-0.04%
ROE(5y)2.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.45%
GM growth 5Y-1.7%
F-Score4
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 2.01
Cap/Depr 108.95%
Cap/Sales 24.67%
Interest Coverage N/A
Cash Conversion 95.49%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z 1.45
F-Score4
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)225.08%
Cap/Depr(5y)197.89%
Cap/Sales(3y)44.31%
Cap/Sales(5y)37.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y-430.25%
EPS Next 2Y-42.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.92%
Revenue growth 3Y23.87%
Revenue growth 5Y21.21%
Sales Q2Q%3.73%
Revenue Next Year5.05%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y65.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year401.41%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y82.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.88%
OCF growth 3Y39.83%
OCF growth 5Y17.19%

BOSTON OMAHA CORP-CL A / BOC FAQ

What is the ChartMill fundamental rating of BOSTON OMAHA CORP-CL A (BOC) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BOC.


What is the valuation status for BOC stock?

ChartMill assigns a valuation rating of 0 / 10 to BOSTON OMAHA CORP-CL A (BOC). This can be considered as Overvalued.


What is the profitability of BOC stock?

BOSTON OMAHA CORP-CL A (BOC) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for BOC stock?

The Earnings per Share (EPS) of BOSTON OMAHA CORP-CL A (BOC) is expected to decline by -430.25% in the next year.